AIG Hospitals study identifies intestinal ultrasound as low-cost, low-carbon diagnostic tool for Inflammatory Bowel Disease
India, Nov. 20 -- New research from Hyderabad-based AIG Hospitals makes a strong case for adopting diagnostic procedures that combine clinical suitability with lower costs and a smaller environmental footprint.
Led by Dr Hardik Rughwani, the EVERGREEN-IBD study, published in the prestigious journal "Alimentary Pharmacology & Therapeutics," found that intestinal ultrasound had the lowest carbon emissions and hospital cost among the imaging tests assessed for inflammatory bowel disease (IBD) care. The findings support its wider adoption for follow-up monitoring where clinically appropriate.
IBD, which includes Crohn's Disease (CD) and Ulcerative Colitis (UC), often requires repeated investigations over a lifetime. Each examination carries...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.